CLASSIFICATION: antimicrotubule agent Special pediatric considerations are noted when applicable, otherwise adult provisions apply. MECHANISM OF ACTION: Paclitaxel is a taxane. Paclitaxel binds to tubulin, the protein component of microtubules, simultaneously promoting their assembly and disassembly to form stable, nonfunctional microtubules.1,2 Although some reports indicate a cross-reactivity rate of 90 % between docetaxel and paclitaxel, others suggest it does not occur consistently.2,3 Stabilization of microtubules blocks cells in the M phase of the cell cycle, inhibiting cell division and causing cell death.2 Paclitaxel acts as a radiosensitizing agent by blocking cells in the G2phase.4 Paclitaxel is an immunosuppressant.5,6 PHARMACOKI...
Jean A Yared, Katherine HR TkaczukUniversity of Maryland School of Medicine, Marlene and Stewart Gre...
Since 1984, when paclitaxel was approved by the FDA for the treatment of advanced ovarian carcinoma,...
Taxol®, an antitumor drug with significant activity, is the first microtubule stabilizing agent desc...
Paclitaxel (Taxol®) is a member of the taxane class of anticancer drugs and one of the most common c...
Dongshan Zhang,1,2 Ruhao Yang,1 Shixuan Wang,2 Zheng Dong1,2 1Departments of Emergency Medicine and ...
CLASSIFICATION: miscellaneous Special pediatric considerations are noted when applicable, otherwise ...
During a screening performed by the National Cancer Institute in the 1960s, the terpenoid paclitaxel...
AbstractSB-T-1213 and IDN5109 are semisynthetic, orally available taxanes that are up to 400-fold mo...
Taxanes represent one of the most promising classes of anticancer agents. Unfortunately, their clini...
CLASSIFICATION: antimicrotubule agent Special pediatric considerations are noted when applicable, ot...
Microtubules are highly dynamic cellular polymers made of αβ-tubulin and associated proteins. They p...
CLASSIFICATION: antimicrotubule agent Special pediatric considerations are noted when applicable, ot...
Objectives Paclitaxel is a potent anti-cancer drug that has exhibited clinical activity against seve...
textabstractThe taxanes are a new class of drugs that exert antitumor activity through a unique mech...
SummaryThe interactions of microtubules with most compounds described as stabilizing agents have bee...
Jean A Yared, Katherine HR TkaczukUniversity of Maryland School of Medicine, Marlene and Stewart Gre...
Since 1984, when paclitaxel was approved by the FDA for the treatment of advanced ovarian carcinoma,...
Taxol®, an antitumor drug with significant activity, is the first microtubule stabilizing agent desc...
Paclitaxel (Taxol®) is a member of the taxane class of anticancer drugs and one of the most common c...
Dongshan Zhang,1,2 Ruhao Yang,1 Shixuan Wang,2 Zheng Dong1,2 1Departments of Emergency Medicine and ...
CLASSIFICATION: miscellaneous Special pediatric considerations are noted when applicable, otherwise ...
During a screening performed by the National Cancer Institute in the 1960s, the terpenoid paclitaxel...
AbstractSB-T-1213 and IDN5109 are semisynthetic, orally available taxanes that are up to 400-fold mo...
Taxanes represent one of the most promising classes of anticancer agents. Unfortunately, their clini...
CLASSIFICATION: antimicrotubule agent Special pediatric considerations are noted when applicable, ot...
Microtubules are highly dynamic cellular polymers made of αβ-tubulin and associated proteins. They p...
CLASSIFICATION: antimicrotubule agent Special pediatric considerations are noted when applicable, ot...
Objectives Paclitaxel is a potent anti-cancer drug that has exhibited clinical activity against seve...
textabstractThe taxanes are a new class of drugs that exert antitumor activity through a unique mech...
SummaryThe interactions of microtubules with most compounds described as stabilizing agents have bee...
Jean A Yared, Katherine HR TkaczukUniversity of Maryland School of Medicine, Marlene and Stewart Gre...
Since 1984, when paclitaxel was approved by the FDA for the treatment of advanced ovarian carcinoma,...
Taxol®, an antitumor drug with significant activity, is the first microtubule stabilizing agent desc...